Immunohistochemical analysis confirmed that diabetes and doxorubicin exposure increased TNF-α, caspase-3, 8-OHdG, and TGF-β1 expression, all of which were attenuated by treatment. This evidence concerns the gene TGFB1 and diabetes mellitus.